Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Collagen mutation causes changes of the microdamage morphology in bone of an OI mouse model.

Dong XN, Zoghi M, Ran Q, Wang X.

Bone. 2010 Dec;47(6):1071-5. doi: 10.1016/j.bone.2010.08.013. Epub 2010 Aug 22.

2.

Increased susceptibility to microdamage in Brtl/+ mouse model for osteogenesis imperfecta.

Davis MS, Kovacic BL, Marini JC, Shih AJ, Kozloff KM.

Bone. 2012 Mar;50(3):784-91. doi: 10.1016/j.bone.2011.12.007. Epub 2011 Dec 20.

3.

Correlations Between Bone Mechanical Properties and Bone Composition Parameters in Mouse Models of Dominant and Recessive Osteogenesis Imperfecta and the Response to Anti-TGF-β Treatment.

Bi X, Grafe I, Ding H, Flores R, Munivez E, Jiang MM, Dawson B, Lee B, Ambrose CG.

J Bone Miner Res. 2017 Feb;32(2):347-359. doi: 10.1002/jbmr.2997. Epub 2016 Oct 20.

4.

Effect of sclerostin antibody treatment in a mouse model of severe osteogenesis imperfecta.

Roschger A, Roschger P, Keplingter P, Klaushofer K, Abdullah S, Kneissel M, Rauch F.

Bone. 2014 Sep;66:182-8. doi: 10.1016/j.bone.2014.06.015. Epub 2014 Jun 19.

PMID:
24953712
5.

Type I collagen mutation alters the strength and fatigue behavior of Mov13 cortical tissue.

Jepsen KJ, Schaffler MB, Kuhn JL, Goulet RW, Bonadio J, Goldstein SA.

J Biomech. 1997 Nov-Dec;30(11-12):1141-7.

PMID:
9456382
6.

Enhanced Wnt signaling improves bone mass and strength, but not brittleness, in the Col1a1(+/mov13) mouse model of type I Osteogenesis Imperfecta.

Jacobsen CM, Schwartz MA, Roberts HJ, Lim KE, Spevak L, Boskey AL, Zurakowski D, Robling AG, Warman ML.

Bone. 2016 Sep;90:127-32. doi: 10.1016/j.bone.2016.06.005. Epub 2016 Jun 11.

7.

Brittle IV mouse model for osteogenesis imperfecta IV demonstrates postpubertal adaptations to improve whole bone strength.

Kozloff KM, Carden A, Bergwitz C, Forlino A, Uveges TE, Morris MD, Marini JC, Goldstein SA.

J Bone Miner Res. 2004 Apr;19(4):614-22. Epub 2004 Jan 12.

8.

Myostatin deficiency partially rescues the bone phenotype of osteogenesis imperfecta model mice.

Oestreich AK, Carleton SM, Yao X, Gentry BA, Raw CE, Brown M, Pfeiffer FM, Wang Y, Phillips CL.

Osteoporos Int. 2016 Jan;27(1):161-70. doi: 10.1007/s00198-015-3226-7. Epub 2015 Jul 16.

PMID:
26179666
9.

Collagen from the osteogenesis imperfecta mouse model (oim) shows reduced resistance against tensile stress.

Misof K, Landis WJ, Klaushofer K, Fratzl P.

J Clin Invest. 1997 Jul 1;100(1):40-5.

10.

The role of water and mineral-collagen interfacial bonding on microdamage progression in bone.

Luo Q, Leng H, Wang X, Zhou Y, Rong Q.

J Orthop Res. 2014 Feb;32(2):217-23. doi: 10.1002/jor.22501. Epub 2013 Oct 10.

11.

Growth hormone injections improve bone quality in a mouse model of osteogenesis imperfecta.

King D, Jarjoura D, McEwen HA, Askew MJ.

J Bone Miner Res. 2005 Jun;20(6):987-93. Epub 2005 Jan 18.

12.

Abnormal mineral-matrix interactions are a significant contributor to fragility in oim/oim bone.

Miller E, Delos D, Baldini T, Wright TM, Pleshko Camacho N.

Calcif Tissue Int. 2007 Sep;81(3):206-14. Epub 2007 Jul 28.

13.

Dietary fluoride restriction does not alter femoral biomechanical strength in col1a2-deficient (oim) mice with type I collagen glomerulopathy.

Carleton SM, Whitford GM, Phillips CL.

J Nutr. 2010 Oct;140(10):1752-6. doi: 10.3945/jn.109.120261. Epub 2010 Aug 19.

PMID:
20724489
14.

Decreasing maternal myostatin programs adult offspring bone strength in a mouse model of osteogenesis imperfecta.

Oestreich AK, Kamp WM, McCray MG, Carleton SM, Karasseva N, Lenz KL, Jeong Y, Daghlas SA, Yao X, Wang Y, Pfeiffer FM, Ellersieck MR, Schulz LC, Phillips CL.

Proc Natl Acad Sci U S A. 2016 Nov 22;113(47):13522-13527. Epub 2016 Nov 7.

15.

Effects of damage morphology on cortical bone fragility.

Diab T, Vashishth D.

Bone. 2005 Jul;37(1):96-102.

PMID:
15897021
16.

Oim mice exhibit altered femur and incisor mineral composition and decreased bone mineral density.

Phillips CL, Bradley DA, Schlotzhauer CL, Bergfeld M, Libreros-Minotta C, Gawenis LR, Morris JS, Clarke LL, Hillman LS.

Bone. 2000 Aug;27(2):219-26.

PMID:
10913914
17.

Does microdamage accumulation affect the mechanical properties of bone?

Burr DB, Turner CH, Naick P, Forwood MR, Ambrosius W, Hasan MS, Pidaparti R.

J Biomech. 1998 Apr;31(4):337-45.

PMID:
9672087
18.

Increased intra-cortical porosity reduces bone stiffness and strength in pediatric patients with osteogenesis imperfecta.

Vardakastani V, Saletti D, Skalli W, Marry P, Allain JM, Adam C.

Bone. 2014 Dec;69:61-7. doi: 10.1016/j.bone.2014.09.003. Epub 2014 Sep 16.

PMID:
25238898
19.

Sclerostin antibody improves skeletal parameters in a Brtl/+ mouse model of osteogenesis imperfecta.

Sinder BP, Eddy MM, Ominsky MS, Caird MS, Marini JC, Kozloff KM.

J Bone Miner Res. 2013 Jan;28(1):73-80. doi: 10.1002/jbmr.1717.

20.

In vivo microdamage is an indicator of susceptibility to initiation and propagation of microdamage in human femoral trabecular bone.

Wu Z, Laneve AJ, Niebur GL.

Bone. 2013 Jul;55(1):208-15. doi: 10.1016/j.bone.2013.02.019. Epub 2013 Feb 28.

Supplemental Content

Support Center